INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Meeting Eye Exam Needs At The Point Of Need
Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.
-
Improving ISR Success Rates In Bioanalysis Of Small Molecule Drugs
Leveraging incurred sample reanalysis (ISR) in your quality control helps your team mitigate risks, establish regulatory compliance, and instill confidence in your pharmacokinetic modeling.
-
Rescuing A Global Program For NDA Success
Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
Navigating The Future Of Clinical Trials: Expert Insights For 2025
The biopharmaceutical industry is undergoing transformative changes to develop more dynamic and efficient frameworks that prioritize patient outcomes in 2025.
-
Making The Lives Of Patients And Research Sites Easier5/14/2025
Most clinical trials overlook one crucial factor: giving sites and patients a voice in how studies are run. That’s starting to change—and the impact is significant.
-
Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies8/29/2025
Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.
-
South Korea And Australia On The Rise As Clinical Research Hubs7/3/2024
Novotech’s vice president emphasizes the expanding clinical presence in the APAC region, with a focus on Australia and South Korea.
-
Addressing Site Selection Challenges In DMD Gene Therapy Studies1/14/2025
Effective site selection is critical for the success of DMD gene therapy trials. This study details innovative methodologies employed to streamline and improve site identification.
-
The Trust Deficit: Is An Overlooked Literacy Gap Stalling Clinical Trial Enrollment?11/7/2025
Here, we examine the critical disconnect in a patient's understanding and how purpose-built AI platforms can translate complex medical language into plain, accessible communication.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.
Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.
-
Ropack's ample available capacity brings efficiency to a wide range of options for the packaging of solid oral dosage. In nearly 250,000 sq. ft., Ropack operates 32 Clean Rooms in modular systems that allow for scalable growth and rapid expansion for packaging in blister, bottle, stick and sachet formats.
-
Read how Biorasi's speed and agility make all the difference in overcoming unique obstacles to rare disease clinical trials.
-
Learn more about the Global ESG Program and how the continued development of sustainability initiatives contributes to positive impact on the environment and the communities in which we operate.
-
Our model combines the depth and experience level of our people with effective tools and processes already in place that are designed to ensure your critical eTMF documents and content are secure, organized, readily accessible, and always in complete compliance with all relevant regulations.